04/23/2025
If you are on compound tirzepatide, please check your email. We sent an email to everyone that is on compound tirzepatide.
The Shot Spot only prescribes compound medications. If you would like a name brand medication, please see your local health care provider.
Compounded GLP-1 medications are medications prescribed by a licensed healthcare provider based on a medical assessment and compounded in a 503(a) Compounding Pharmacy or 503(b) Outsourcing Facility. The Shot Spot exclusively works with licensed compounding pharmacies in the United States.
Compounded medications do not undergo pre-market review or an FDA-approval process. They may differ in efficacy, safety, risk, and side-effect profiles from commercially available or FDA-approved drugs. Data from clinical trials on FDA-approved medications should not be used to make assessments related to compounded medications.
Ozempic®, Wegovy®, Mounjaro® and Zepbound® are not compounded.
Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion. Wegovy® and Zepbound® are FDA-approved for weight loss. Ozempic® and Wegovy® are the registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are the registered trademarks of Eli Lilly. The Shot Spot is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly.
